NVS — NOVARTIS A G

Ownership history in HoyleCohen, LLC · 25 quarters on record

This page tracks every 13F SEC filing in which HoyleCohen, LLC reported a position in NOVARTIS A G (NVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

🏔 Peak position

0.08% (2020 Q1)

📊 Avg. % of fund

0.05%

📅 First filed

2017 Q4

📅 Last filed

2024 Q1

⏱ Quarters held

Position Intelligence

HoyleCohen, LLC × NVS AI Analytics

📉 HoyleCohen, LLC underperformed the S&P 500 by –5.7% annually on this NVS position. Timing score: 50% (8/16 decisions correct). Average cost basis: $72.32. Maximum drawdown during holding period: –13.4%.

📈 Position Alpha vs SPY

-5.7%

annualised excess return

❌ Significantly underperformed the S&P 500 by 5.7% ann.
23 quarters analyzed

⏱️ Timing Score

50%

➡️ Neutral timing — roughly coin-flip accuracy on add/trim calls.
8 of 16 add/trim decisions correct

💰 Entry Quality

$72.32

+25.2% vs current ($90.51)

Best entry: $66.28 (2019 Q1) · Worst: $91.83 (2023 Q3)

🛡️ Drawdown Resilience

–13.4%

max drawdown while held

💎 No drawdown exceeding 20% during the holding period — exceptionally stable.

💪 Fund Conviction

39%

buy-side decisions

7 adds · 11 trims. Bought during 2 of 10 down-price quarters. 📉 Predominantly trimming — distribution phase.

📡 Position Trajectory

→ Stable

last 4–5 quarters trend

⚖️ Portfolio weight has remained relatively stable — conviction maintained.
Currently 0.03% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return × 4 (annualised). Not investment advice.

% of Fund (quarterly) NVS price (monthly, adj. close)

📋 Quarterly Holdings History 10 quarters ▾

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2024 Q1	ADDED	4,147	+229	+5.8%	0.03%	$401K	$90.51
2023 Q4	UNCHANGED	3,918	—	0%	0.03%	$396K	$91.03
2023 Q3	ADDED	3,918	+225	+6.1%	0.04%	$399K	$91.83
2023 Q2	UNCHANGED	3,693	—	0%	0.03%	$373K	$90.98
2023 Q1	REDUCED	3,693	-1,000	-21.3%	0.03%	$340K	$82.94
2022 Q4	REDUCED	4,693	-467	-9.1%	0.04%	$426K	$78.38
2022 Q3	REDUCED	5,160	-99	-1.9%	0.04%	$392K	$65.67
2022 Q2	REDUCED	5,259	-94	-1.8%	0.05%	$445K	$73.03
2022 Q1	REDUCED	5,353	-220	-3.9%	0.04%	$470K	$75.82
2021 Q4	ADDED	5,573	+651	+13.2%	0.04%	$487K	$72.54

🏢 Other funds also holding NVS

As of 2025 Q4 — sorted by position size

Foresight Global Investors, Inc. 11.63% Martin Investment Management, LLC 3Y 7Y 8.16% Promethos Capital, LLC 7.78% WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 3Y 7Y 3.95% First Fiduciary Investment Counsel, Inc. 3Y 7Y 3.62% SCHARF INVESTMENTS, LLC 3Y 7Y 3.57% MANAGED ASSET PORTFOLIOS, LLC 3Y 7Y 3.31% Cullen Capital Management, LLC 3Y 7Y 3.13% Eldred Rock Partners, LLC 2.92% Solutions 4 Wealth, Ltd 2.75%

← Back to HoyleCohen, LLC Holdings

NVS — NOVARTIS A G

Position Intelligence

🏢 Other funds also holding NVS

Welcome to 13Foresight!